It’s time to stop treating Medicare pricing like the gospel truth. Many are falling into the trap of accepting those rates as fair market value, but that’s a massive mistake. Getting granular with your line items for every therapeutic indication is non-negotiable if you want to understand real costs. Whether that means building out a solid rationale or getting creative with your research tools, don't settle for the benchmark just because it’s the standard. Dive deeper, question the status quo, and start budgeting with a sharper eye. #HealthcareFinance #Medicare #BudgetingTips #MarketValue #BusinessStrategy - @dansfera